Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225344263> ?p ?o ?g. }
- W4225344263 endingPage "175883592210868" @default.
- W4225344263 startingPage "175883592210868" @default.
- W4225344263 abstract "Clinical stage 1 (CS1) nonseminomatous (NS) germ cell tumors involve a 30% probability of relapse upon surveillance. Adjuvant chemotherapy with one course of bleomycin, etoposide, and cisplatin (1xBEP) can reduce this risk to <5%. However, 1xBEP results are based solely on five controlled trials from high-volume centers. We analyzed the outcome in a real-life population.In a multicentric international study, 423 NS CS1 patients receiving 1xBEP were retrospectively evaluated. Median follow-up was 37 (range, 6-89) months. Primary end points were relapse-free and overall survival evaluated after 5 years. We also looked at associations of relapse with clinico-pathological factors using stratified Kaplan-Meier methods and Cox regression models. Treatment modality and outcome of recurrences were analyzed descriptively.The 5-year relapse-free survival rate was 96.2%. Thirteen patients (3.1%; 95% confidence interval, 1.65-5.04%) relapsed after a median time of 13 months, of which 10 were salvaged (77%). Relapses were mostly confined to retroperitoneal nodes. Three patients succumbed, two to disease progression and one to toxicity of chemotherapy. Pathological stage >pT2 was significantly associated with relapse rate.The relapse rate of 3.1% found in this population of NS CS1 patients treated with 1xBEP at the routine care level was not inferior to the median rate of 2.3% reported from a meta-analysis of controlled trials. Also, the cure rate of relapses of 77% is consistent with the previously reported rate of 80%. This study clearly shows that the 1xBEP regimen represents a safe treatment for NS CS1 patients." @default.
- W4225344263 created "2022-05-05" @default.
- W4225344263 creator A5003804188 @default.
- W4225344263 creator A5006483196 @default.
- W4225344263 creator A5007128066 @default.
- W4225344263 creator A5007774954 @default.
- W4225344263 creator A5010990966 @default.
- W4225344263 creator A5011305627 @default.
- W4225344263 creator A5014987293 @default.
- W4225344263 creator A5015085799 @default.
- W4225344263 creator A5019298885 @default.
- W4225344263 creator A5020072048 @default.
- W4225344263 creator A5022470915 @default.
- W4225344263 creator A5022899913 @default.
- W4225344263 creator A5023788971 @default.
- W4225344263 creator A5029925615 @default.
- W4225344263 creator A5030071814 @default.
- W4225344263 creator A5032459418 @default.
- W4225344263 creator A5037809282 @default.
- W4225344263 creator A5038825854 @default.
- W4225344263 creator A5043378490 @default.
- W4225344263 creator A5048118430 @default.
- W4225344263 creator A5050740286 @default.
- W4225344263 creator A5051508644 @default.
- W4225344263 creator A5051959181 @default.
- W4225344263 creator A5059511901 @default.
- W4225344263 creator A5062121101 @default.
- W4225344263 creator A5062658572 @default.
- W4225344263 creator A5064083940 @default.
- W4225344263 creator A5065089909 @default.
- W4225344263 creator A5070280595 @default.
- W4225344263 creator A5074802220 @default.
- W4225344263 creator A5074979348 @default.
- W4225344263 creator A5075155205 @default.
- W4225344263 creator A5088679927 @default.
- W4225344263 creator A5089948892 @default.
- W4225344263 creator A5090241317 @default.
- W4225344263 creator A5090255439 @default.
- W4225344263 creator A5090686439 @default.
- W4225344263 date "2022-01-01" @default.
- W4225344263 modified "2023-10-18" @default.
- W4225344263 title "Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study" @default.
- W4225344263 cites W1150091873 @default.
- W4225344263 cites W1550275457 @default.
- W4225344263 cites W1590471737 @default.
- W4225344263 cites W1921920391 @default.
- W4225344263 cites W1965292019 @default.
- W4225344263 cites W1968178814 @default.
- W4225344263 cites W1977876143 @default.
- W4225344263 cites W2015712245 @default.
- W4225344263 cites W2083637172 @default.
- W4225344263 cites W2098064059 @default.
- W4225344263 cites W2098838369 @default.
- W4225344263 cites W2105748861 @default.
- W4225344263 cites W2108328835 @default.
- W4225344263 cites W2108522817 @default.
- W4225344263 cites W2141964341 @default.
- W4225344263 cites W2148800081 @default.
- W4225344263 cites W2153988016 @default.
- W4225344263 cites W2160890421 @default.
- W4225344263 cites W2163826522 @default.
- W4225344263 cites W2166803757 @default.
- W4225344263 cites W2340182039 @default.
- W4225344263 cites W2444169918 @default.
- W4225344263 cites W2467424047 @default.
- W4225344263 cites W2480687374 @default.
- W4225344263 cites W2519651162 @default.
- W4225344263 cites W2521492654 @default.
- W4225344263 cites W2546531818 @default.
- W4225344263 cites W2620580140 @default.
- W4225344263 cites W2751061221 @default.
- W4225344263 cites W2752618923 @default.
- W4225344263 cites W2754802857 @default.
- W4225344263 cites W2769562629 @default.
- W4225344263 cites W2789683762 @default.
- W4225344263 cites W2796236069 @default.
- W4225344263 cites W2807994238 @default.
- W4225344263 cites W2883060707 @default.
- W4225344263 cites W2886615577 @default.
- W4225344263 cites W2901456761 @default.
- W4225344263 cites W2903880183 @default.
- W4225344263 cites W2913253891 @default.
- W4225344263 cites W2917815963 @default.
- W4225344263 cites W2936876218 @default.
- W4225344263 cites W2989795562 @default.
- W4225344263 cites W2994187593 @default.
- W4225344263 cites W2995820724 @default.
- W4225344263 cites W2997252926 @default.
- W4225344263 cites W3016712946 @default.
- W4225344263 cites W3028514939 @default.
- W4225344263 cites W3046859958 @default.
- W4225344263 cites W3047713916 @default.
- W4225344263 cites W3119115985 @default.
- W4225344263 cites W3126003151 @default.
- W4225344263 cites W3134783283 @default.
- W4225344263 cites W3150204614 @default.
- W4225344263 cites W3190623864 @default.
- W4225344263 cites W4211258097 @default.